# Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2

> **NCT01443338** · PHASE4 · UNKNOWN · sponsor: **Ministry of Health, China** · enrollment: 720 (estimated)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Triptergium Wilfordii
- **DRUG:** Acitretin

## Key facts

- **NCT ID:** NCT01443338
- **Lead sponsor:** Ministry of Health, China
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 720 (ESTIMATED)
- **Last updated:** 2011-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01443338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01443338, "Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01443338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*